The changing epidemiology of severe infections in the ICU

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Pharmacokinetics of cefetamet pivoxil and interaction with cisapride and N- acetylcysteine Klaus-Jürgen Gutleben, Jörg Eller, Jessica Vöckler, Margot.

Grepafloxacin: microbiological properties

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.

Herpes zoster in non-hospitalized children

Atypical respiratory pathogens

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hydatid disease Clinical Microbiology and Infection

Didier Guillemot, Claude Carbon Clinical Microbiology and Infection

Link between intracellular pathogens and cardiovascular diseases

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription B. Maraha, M. Bonten, H. Fiolet,

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci Keith Klugman, Fred Goldstein,

Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility Javier Garau, Walter Wilson,

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

G. Höffken Clinical Microbiology and Infection

Cephalosporins: a pharmacological update

Epidemiology of opportunistic infections in AIDS patients

Laboratory diagnosis and biosafety issues of biological warfare agents

Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections P.S. Hicks, B.

Ventilator-associated pneumonia—Understanding epidemiology and pathogenesis to guide prevention and empiric therapy Patrick Francioli, Jean Chastre,

Sepsis and neutropenia induced by clozapine

Antibiotic usage and the incidence of resistance

Uncommon opportunistic fungi: new nosocomial threats

André Bryskier Clinical Microbiology and Infection

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

G.R. Davies Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Community-acquired pneumonia: epidemiologic and clinical consideration

Grepafloxacin: pharmacokinetics and tissue penetration

Newly identified respiratory viruses associated with acute lower respiratory tract infections in children in Lanzou, China, from 2006 to 2009 Y. Jin,

Reducing antibiotic use in influenza: challenges and rewards

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Clinical infection services—the Leiden experience

Ethan Rubinstein, Itzhak Levy Clinical Microbiology and Infection

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party Dilip Nathwani, Christopher Conlon Clinical.

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis Miles Denton, Kevin G Kerr, Fraser Lewis Clinical.

Clinical Microbiology and Infection

Empiric therapy of bacterial infections in severe neutropenia

Overview of cefixime use in community-acquired infections

Sanford Chodosh Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

L.S. Christensen, T.V. Madsen, T. Barfod

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party Dilip Nathwani, Christopher Conlon Clinical.

Fernando Baquero, John F

The future of diagnostic bacteriology

Vincent Calvez, Marc Grandadam Clinical Microbiology and Infection

Presentation transcript:

The changing epidemiology of severe infections in the ICU Michel Wolff, Christian Brun-Buisson, Hartmut Lode, Dilip Mathai, David Lewi, Didier Pittet Clinical Microbiology and Infection Volume 3, Pages S36-S47 (April 1997) DOI: 10.1111/j.1469-0691.1997.tb00645.x Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Most frequently-reported ICU-acquired infections in the EPIIC study. From Vincent et al. 8. (LRTI = lower respiratory tract infection (pneumonia excluded), UTI = urinary tract infection). With permission of the American Medical Association. Clinical Microbiology and Infection 1997 3, S36-S47DOI: (10.1111/j.1469-0691.1997.tb00645.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Secular trends in the rates of isolation of selected bloodstream isolates. From Pittet and Wenzel 10. With permission of the American Medical Association. Clinical Microbiology and Infection 1997 3, S36-S47DOI: (10.1111/j.1469-0691.1997.tb00645.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions